☆ 4.6 Letter

SphK1 inhibitor potentiates the anti-cancer effect of EGCG on leukaemia cells

BRITISH JOURNAL OF HAEMATOLOGY (2017)

Get Full Text
Add to Collection

Journal

BRITISH JOURNAL OF HAEMATOLOGY
Volume 178, Issue 1, Pages 155-158

Publisher

WILEY
DOI: 10.1111/bjh.14119

Keywords

sphingosine kinase 1; chronic lymphocytic leukaemia; safingol; epigallocatechin-O-3-gallate; apoptosis

Categories

Hematology

Funding

  1. Japan Society for the Promotion of Science [22228002, 15H02448]
  2. International Myeloma Foundation (IMF) Japan's grants
  3. JSPS [15K18821]
  4. Grants-in-Aid for Scientific Research [15H02448, 15K18821] Funding Source: KAKEN

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.